Escitalopram and Normochromic normocytic anaemia - a phase IV clinical study of FDA data

Summary:

Normochromic normocytic anaemia is found among people who take Escitalopram, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Escitalopram and have Normochromic normocytic anaemia. It is created by eHealthMe based on reports of 59,851 people who have side effects when taking Escitalopram from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 21, 2022

59,851 people reported to have side effects when taking Escitalopram.
Among them, 142 people (0.24%) have Normochromic normocytic anaemia.

What is Escitalopram?

Escitalopram has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 62,458 Escitalopram users for its effectiveness, alternative drugs and more.

What is Normochromic normocytic anaemia?

Normochromic normocytic anaemia (forms of anaemia in which the average size and haemoglobin content of the red blood cells are within normal limits) is found to be associated with 1,073 drugs and 604 conditions by eHealthMe.

Number of Escitalopram and Normochromic normocytic anaemia reports submitted per year:

Could Escitalopram cause Normochromic normocytic anaemia?

Gender of people who have Normochromic normocytic anaemia when taking Escitalopram*:

Click here to view

Age of people who have Normochromic normocytic anaemia when taking Escitalopram *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Escitalopram and have Normochromic normocytic anaemia?

Check whether Normochromic normocytic anaemia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .

Related studies

How severe was Normochromic normocytic anaemia and when was it recovered:

Normochromic normocytic anaemia in Escitalopram

Expand to all the drugs that have ingredients of escitalopram oxalate:

Normochromic normocytic anaemia and drugs with ingredients of escitalopram oxalate (49 reports)

Alternative drugs to, pros and cons of Escitalopram:

Escitalopram (62,458 reports)

Common Escitalopram side effects:

Fatigue (feeling of tiredness): 4,064 reports
Drug ineffective: 3,486 reports
Diarrhea: 2,974 reports
Dizziness: 2,937 reports
Stress and anxiety: 2,901 reports
Headache (pain in head): 2,848 reports
Weakness: 2,535 reports

Browse all side effects of Escitalopram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Normochromic normocytic anaemia treatments and more:

Normochromic normocytic anaemia (4,034 reports)

COVID vaccines that are related to Normochromic normocytic anaemia:

Common drugs associated with Normochromic normocytic anaemia:

All the drugs that are associated with Normochromic normocytic anaemia:

Normochromic normocytic anaemia (1,073 drugs)

Common conditions associated with Normochromic normocytic anaemia:

High blood pressure: 328 reports
Osteoporosis: 161 reports
Atrial fibrillation/flutter: 147 reports
Depression: 139 reports
Rheumatoid arthritis: 136 reports
Pain: 122 reports

All the conditions that are associated with Normochromic normocytic anaemia:

Normochromic normocytic anaemia (604 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on escitalopram oxalate (the active ingredients of Escitalopram) and Escitalopram (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.